<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01351883</url>
  </required_header>
  <id_info>
    <org_study_id>HR-98-089</org_study_id>
    <nct_id>NCT01351883</nct_id>
  </id_info>
  <brief_title>Enteric Immune-nutrition Formula (ANOM®) for Patients Receiving Major Upper Gastrointestinal Surgery</brief_title>
  <acronym>ANOM</acronym>
  <official_title>Peri-operative Usage of Enteric Immune-nutrition Formula (ANOM®) Versus Standard Formula for Patients Received Major Upper Gastrointestinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cheng-Kung University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perioperative usage of immunonutrition (ANOM®) can attenuate the pro-inflammatory cytokines
      and reduce postoperative infectious complications and length of hospital stay after major
      upper gastrointestinal surgery.

      (ANOM®)immunonutrition product name
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Perioperative usage of immunonutrition can attenuate the pro-inflammatory
      cytokines and reduce postoperative infectious complications and length of hospital stay after
      major upper gastrointestinal surgery. The aim of this study was to elucidate the effect of
      immunomodulating diets, ANOM®, on surgical outcome in elective major upper gastrointestinal
      tract operations.

      Material and Methods:

      Design: Prospective, randomized, controlled trial. Participants: Seventy upper
      gastrointestinal tract cancer patients planned to undergo major upper gastrointestinal
      surgery in eesophagus、stomach、pancreas or duodenum, Interventions: Patients will be divided
      randomly into two groups to receive ANOM® or standard diet. Before surgery, 800ml ANOM® or
      standard diet (SEN) will be given for 5 days by mouth. After operation, 5% Distill water
      (D5W) combined with ANOM® or standard diet since the 2nd post-operation day (POD2) until day
      14 (POD14) or until discharged day by enteric route using nasogastric tube(NG) tube or
      jejunostomy. Postoperative parenteral nutrition will be given to maintain adequate nutrition.

      Clinical Assessment: The preoperative and postoperative immunological parameters, infection
      complications, and hospital stay will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative infectious complication</measure>
    <time_frame>POD 14 or discharged day</time_frame>
    <description>we want to evaluate the effect of ANOM on postoperative infectious complication after early feeding with ANOM</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>immunological parameters</measure>
    <time_frame>POD 14 or discharged day</time_frame>
    <description>we want to compare the immunological parameters, IL-6, with stand diet group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free radicles -TBARS</measure>
    <time_frame>POD 14 or discharged day</time_frame>
    <description>we will esitimate the difference blood level of free radicles by ELISA and compared with that in the standard diet group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunological parameters</measure>
    <time_frame>POD14 or discharged day</time_frame>
    <description>we will compare the immunological parameters, IL-8, with the stand diet group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunological parameter</measure>
    <time_frame>POD14 or discharged day</time_frame>
    <description>We will compare the immunological parameter, IL-1, with the standard diet group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunological parameter</measure>
    <time_frame>POD14 or discharged day</time_frame>
    <description>We will compare the immunological parameter, IL-10, with the standard diet group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunological parameters</measure>
    <time_frame>POD14 or discharged day</time_frame>
    <description>We will compare the immunological parameter, TNF-a, with the standard diet group</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Chronic Upper Gastrointestinal Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Standard enteral nutrition supplement</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>regular standard enteral nutrition(SEN) was made by hospital for patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ANOM</intervention_name>
    <description>the ANOM was given 800ml per day before operation, and added from POD2 to POD 14 gradually from 400ml to 1200ml</description>
    <arm_group_label>Standard enteral nutrition supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ranged from 18 to 80 years old

          2. Patients with upper gastrointestinal diseases, and was planning to receive elective
             major upper gastrointestinal tract surgery, such as subtotal gastrectomy, proximal
             gastrectomy, total gastrectomy, esophagectomy, pancreatectomy,
             pancreaticoduodenectomy, duodenectomy, etc.

          3. Patient is able to understand the requirements of the study and signs the Informed
             Consent Form.

        Exclusion Criteria:

          1. Patient with severe malnutrition condition, albumin &lt; 2.6mg/ml

          2. Patient with severe pulmonary, cardiovascular, renal or hepatic disease

          3. Patient with immunosuppressive therapy or immunological disease recently

          4. Patient with on-going infection with any condition

          5. Patient with emergency operation

          6. Patient with widespread metastatic disease before surgery

          7. Patient with bowel obstruction disease

          8. Investigator judges as subjects to be inappropriate for the clinical study (e.g.,
             patient with severe complications)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan-Shen Shan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cheng-Kung University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan-Shen Shan, MD,PhD</last_name>
    <phone>88662353535</phone>
    <phone_ext>5181</phone_ext>
    <email>ysshan@mail.ncku.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cheng Kung University Hospital</name>
      <address>
        <city>Tainan</city>
        <zip>70428</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan-Shen Shan, MD,PhD</last_name>
      <phone>88662353535</phone>
      <phone_ext>5181</phone_ext>
      <email>ysshan@mail.ncku.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Yan-Shen Shan, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pin-wen Lin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ai-Wen Kao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Surgery, Tainan Hospital, Department of Health, Executive Yuan</name>
      <address>
        <city>Tainan</city>
        <zip>704</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai-Hsi Hsu, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Kai-Hsi Hsu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2011</study_first_submitted>
  <study_first_submitted_qc>May 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2011</study_first_posted>
  <last_update_submitted>May 10, 2011</last_update_submitted>
  <last_update_submitted_qc>May 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Benjamin Hsieh/ Product manager</name_title>
    <organization>Taiwan Otsuka Pharmaceutical Co., Ltd.</organization>
  </responsible_party>
  <keyword>immunomodulating diet</keyword>
  <keyword>postoperative infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

